Evolent Health, Inc.
EVH · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$61,623 | -$113,040 | -$19,164 | -$37,601 |
| Dep. & Amort. | $125,615 | $123,415 | $67,195 | $60,037 |
| Deferred Tax | -$2,816 | -$31,272 | $342 | -$526 |
| Stock-Based Comp. | $39,746 | $40,501 | $33,981 | $16,711 |
| Change in WC | -$116,557 | $21,892 | -$104,441 | -$22,489 |
| Other Non-Cash | $34,400 | $101,086 | $10,534 | $22,615 |
| Operating Cash Flow | $18,765 | $142,582 | -$11,553 | $38,747 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$24,893 | -$28,745 | -$38,361 | -$24,983 |
| Net Acquisitions | $0 | $870 | $5,552 | $14,218 |
| Inv. Purchases | -$7,321 | $0 | -$5,552 | -$2,995 |
| Inv. Sales/Matur. | $0 | $0 | $5,552 | $500 |
| Other Inv. Act. | -$30,718 | -$387,669 | -$226,306 | -$2,526 |
| Investing Cash Flow | -$62,932 | -$415,544 | -$259,115 | -$15,786 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $58,576 | $183,293 | $219,740 | -$37,687 |
| Stock Issued | $3,461 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$18,318 | $0 |
| Dividends Paid | -$20,085 | -$18,793 | $0 | -$1,300 |
| Other Fin. Act. | -$42,517 | $116,840 | -$69,881 | $9,439 |
| Financing Cash Flow | -$565 | $281,340 | $131,541 | -$29,548 |
| Forex Effect | -$229 | -$79 | -$657 | -$52 |
| Net Chg. in Cash | -$44,961 | $8,299 | -$139,784 | -$6,639 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $223,457 | $215,158 | $354,942 | $361,581 |
| End Cash | $178,496 | $223,457 | $215,158 | $354,942 |
| Free Cash Flow | -$6,128 | $113,837 | -$49,914 | $13,764 |